Trivedi PJ, Adams DH. Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease pitfalls and promise. J Crohns Colitis. 2018;12:1508. https://doi.org/10.1093/ecco-jcc/jjy130.

Article  PubMed  PubMed Central  Google Scholar 

Mello JDC, Gomes LEM, Silva JF, et al. The role of chemokines and adipokines as biomarkers of Crohn’s disease activity: a systematic review of the literature. Am J Transl Res. 2021;13:8561–74.

CAS  PubMed  PubMed Central  Google Scholar 

Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–21. https://doi.org/10.1056/NEJMra052723.

Article  CAS  PubMed  Google Scholar 

Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891–928. https://doi.org/10.1146/annurev.immunol.22.012703.104543.

Article  CAS  PubMed  Google Scholar 

Carlsen HS, Baekkevold ES, Johansen FE, Haraldsen G, Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut. 2002;51:364–71. https://doi.org/10.1136/gut.51.3.364.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998;187:655–60. https://doi.org/10.1084/jem.187.4.655.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hussain M, Adah D, Tariq M, Lu Y, Zhang J, Liu J. CXCL13/CXCR5 signaling axis in cancer. Life Sci. 2019;227:175–86. https://doi.org/10.1016/j.lfs.2019.04.053.

Article  CAS  PubMed  Google Scholar 

Kain MJ, Owens BM. Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis. Immunology. 2013;140:12–21. https://doi.org/10.1111/imm.12119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621–63. https://doi.org/10.1146/annurev-immunol-031210-101400.

Article  CAS  PubMed  Google Scholar 

Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1. Nature. 1998;391:799–803. https://doi.org/10.1038/35876.

Article  CAS  PubMed  Google Scholar 

Wang B, Wang M, Ao D, Wei X. CXCL13-CXCR5 axis: regulation in inflammatory diseases and cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188799. https://doi.org/10.1016/j.bbcan.2022.188799.

Article  CAS  PubMed  Google Scholar 

Pan Z, Zhu T, Liu Y, Zhang N. Role of the CXCL13/CXCR5 axis in autoimmune diseases. Front Immunol. 2022;13:850998. https://doi.org/10.3389/fimmu.2022.850998.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87:1037–47. https://doi.org/10.1016/s0092-8674(00)81798-5.

Article  PubMed  Google Scholar 

Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A. 1997;94:9302–7. https://doi.org/10.1073/pnas.94.17.9302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ansel KM, Ngo VN, Hyman PL, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309–14. https://doi.org/10.1038/35018581.

Article  CAS  PubMed  Google Scholar 

Gudowska-Sawczuk M, Mroczko B. Chemokine ligand 13 (CXCL13) in neuroborreliosis and neurosyphilis as selected spirochetal neurological diseases: a review of its diagnostic significance. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21082927.

Article  PubMed  PubMed Central  Google Scholar 

Tsai CH, Chen CJ, Gong CL, et al. CXCL13/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression. Cell Death Dis. 2021;12:846. https://doi.org/10.1038/s41419-021-04136-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110–4. https://doi.org/10.1038/nature20810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Liu Y, Liu CX, Jiang YM. CXCL13 is elevated in inflammatory bowel disease in mice and humans and is implicated in disease pathogenesis. Front Immunol. 2022;13:997862. https://doi.org/10.3389/fimmu.2022.997862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Rajkumar S, Lai Y, et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front Immunol. 2023;14:1204777. https://doi.org/10.3389/fimmu.2023.1204777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schiffer L, Kümpers P, Davalos-Misslitz AM, et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant. 2009;24:3708–12. https://doi.org/10.1093/ndt/gfp343.

Article  CAS  PubMed  Google Scholar 

Kobayashi S, Watanabe T, Suzuki R, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360–71. https://doi.org/10.1002/eji.201546043.

Article  CAS  PubMed  Google Scholar 

Monteleone G, Moscardelli A, Colella A, Marafini I, Salvatori S. Immune-mediated inflammatory diseases: common and different pathogenic and clinical features. Autoimmun Rev. 2023;22:103410. https://doi.org/10.1016/j.autrev.2023.103410.

Article  CAS  PubMed  Google Scholar 

Beyaert R, Beaugerie L, Van Assche G, et al. Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer. 2013;12:98. https://doi.org/10.1186/1476-4598-12-98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol. 2016;7:1081. https://doi.org/10.3389/fmicb.2016.01081.

Article  PubMed  PubMed Central  Google Scholar 

Bezzio C, Della Corte C, Vernero M, Di Luna I, Manes G, Saibeni S. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therap Adv Gastroenterol. 2022;15:17562848221115312. https://doi.org/10.1177/17562848221115312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl. 2010;85:2–10. https://doi.org/10.3899/jrheum.091461.

Article  PubMed